Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (31-40 of 328) with videos related to

Pageof 33
Sort By:
Expert Review of Anticancer Therapy|March 23, 2011
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphomaAhmad S Halwani, Brian K Link
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Antibody therapy of lymphomaGeorge J Weiner, Brian K Link
Spatial Vision|January 1, 1987
Sensitivity to corners in flow patternsN K Link, S W Zucker
Clinical Lymphoma & Myeloma|December 17, 2008
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomasLori J Rosenstein, Brian K Link
Leukemia & Lymphoma|December 30, 1998
Monoclonal antibodies in the treatment of human B-cell malignanciesB K Link, G J Weiner
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Seminars in Oncology|July 19, 2003
Post-treatment surveillance of patients with lymphoma treated with curative intentJames E Wooldridge, Brian K Link
Expert Opinion on Biological Therapy|March 10, 2004
Monoclonal antibody therapy of B cell lymphomaGeorge J Weiner, Brian K Link
Blood|June 15, 1993
Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cellsB K Link, G J Weiner
Pageof 33

Showing results (31-40 of 328) with videos related to

Sort By:
Pageof 33
Expert Review of Anticancer Therapy|March 23, 2011
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphomaAhmad S Halwani, Brian K Link
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Antibody therapy of lymphomaGeorge J Weiner, Brian K Link
Spatial Vision|January 1, 1987
Sensitivity to corners in flow patternsN K Link, S W Zucker
Clinical Lymphoma & Myeloma|December 17, 2008
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomasLori J Rosenstein, Brian K Link
Leukemia & Lymphoma|December 30, 1998
Monoclonal antibodies in the treatment of human B-cell malignanciesB K Link, G J Weiner
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Seminars in Oncology|July 19, 2003
Post-treatment surveillance of patients with lymphoma treated with curative intentJames E Wooldridge, Brian K Link
Expert Opinion on Biological Therapy|March 10, 2004
Monoclonal antibody therapy of B cell lymphomaGeorge J Weiner, Brian K Link
Blood|June 15, 1993
Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cellsB K Link, G J Weiner
Pageof 33